RS49808B - Farmaceutska suspenzija koja sadrži nevirapin hemihidrat - Google Patents
Farmaceutska suspenzija koja sadrži nevirapin hemihidratInfo
- Publication number
- RS49808B RS49808B YUP-98/00A YU9800A RS49808B RS 49808 B RS49808 B RS 49808B YU 9800 A YU9800 A YU 9800A RS 49808 B RS49808 B RS 49808B
- Authority
- RS
- Serbia
- Prior art keywords
- nevirapine
- suspenzion
- pharmacevtical
- hemihydrate
- nevirapine hemihydrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Farmaceutska kompozicija koja se sastoji uglavnom od sledećih sastojaka, u navedenom odgovarajućem opsegu količina: Sastojak Količina (g/100 ml) nevirapin hemihidrat 0,1-50 Carbomer 934P, NF 0,17-0,22 Polysorate 80, NF 0,01-0,2 rastvor sorbitola, USP 5-30 saharoza, NF 5-30 metilparaben, NF 0,15-0,2 propilparaben, NF 0,02-0,24 natrijum-hidroksid, NF* q.s. do pH 5,5-6,0 prečišćena voda USP q.s. ad 100,0 ml *pripremljen 20% rastvor pri čemu je veličina čestice nevirapina izmedju 1 i 150 mikrometra u prečiniku.Prijava sadrži još 3 patentna zahteva.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5680397P | 1997-08-25 | 1997-08-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU9800A YU9800A (sh) | 2001-12-26 |
| RS49808B true RS49808B (sr) | 2008-08-07 |
Family
ID=22006658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YUP-98/00A RS49808B (sr) | 1997-08-25 | 1998-08-11 | Farmaceutska suspenzija koja sadrži nevirapin hemihidrat |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US6172059B1 (sr) |
| EP (1) | EP1019058B1 (sr) |
| JP (1) | JP3472261B2 (sr) |
| KR (1) | KR100426516B1 (sr) |
| CN (1) | CN1197578C (sr) |
| AR (2) | AR016869A1 (sr) |
| AT (1) | ATE326971T1 (sr) |
| AU (1) | AU742761B2 (sr) |
| BG (1) | BG64337B1 (sr) |
| BR (1) | BR9811994B1 (sr) |
| CA (1) | CA2301646C (sr) |
| CL (1) | CL2008003111A1 (sr) |
| CO (1) | CO4970742A1 (sr) |
| CY (1) | CY1105228T1 (sr) |
| CZ (1) | CZ290667B6 (sr) |
| DE (1) | DE69834655T2 (sr) |
| DK (1) | DK1019058T3 (sr) |
| EG (1) | EG24075A (sr) |
| ES (1) | ES2265666T3 (sr) |
| HK (1) | HK1027975A1 (sr) |
| HR (1) | HRP980461B1 (sr) |
| HU (1) | HU226063B1 (sr) |
| ID (1) | ID21650A (sr) |
| IL (1) | IL134185A (sr) |
| MY (1) | MY122272A (sr) |
| NO (1) | NO326226B1 (sr) |
| NZ (1) | NZ503414A (sr) |
| PE (1) | PE105799A1 (sr) |
| PL (1) | PL192361B1 (sr) |
| PT (1) | PT1019058E (sr) |
| RS (1) | RS49808B (sr) |
| RU (1) | RU2196584C2 (sr) |
| SA (1) | SA98190680B1 (sr) |
| TR (1) | TR200000490T2 (sr) |
| TW (1) | TW450812B (sr) |
| UA (1) | UA44370C2 (sr) |
| WO (1) | WO1999009990A1 (sr) |
| ZA (1) | ZA987623B (sr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002092095A1 (en) * | 2001-05-11 | 2002-11-21 | Boehringer Ingelheim International Gmbh | Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine |
| AU2003225108A1 (en) * | 2002-04-23 | 2003-11-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for reduction of residual organic solvent in carbomer |
| NZ566796A (en) * | 2005-08-31 | 2011-04-29 | Cipla Ltd | Pharmaceutical combinations containing lamivudine, stavudine and nevirapine |
| US20110082161A1 (en) * | 2008-06-30 | 2011-04-07 | Lieven Elvire Colette Baert | Powders for reconstitution |
| BR112012011095A2 (pt) * | 2009-11-10 | 2015-10-06 | Univ Northwest | método para aumentar a solubilidade de uma composição inibidora de transcriptase |
| CN102725293A (zh) * | 2009-12-17 | 2012-10-10 | 西北大学 | 奈韦拉平的多晶型形式及其制备 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366972A (en) | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
| CA2030056C (en) * | 1989-11-17 | 1995-10-17 | Karl D. Hargrave | 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection |
| US5571912A (en) * | 1990-10-19 | 1996-11-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines |
| DE4403311C1 (de) * | 1994-02-03 | 1995-04-20 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on) |
-
1998
- 1998-08-11 CA CA002301646A patent/CA2301646C/en not_active Expired - Fee Related
- 1998-08-11 RS YUP-98/00A patent/RS49808B/sr unknown
- 1998-08-11 PT PT98939312T patent/PT1019058E/pt unknown
- 1998-08-11 AU AU87771/98A patent/AU742761B2/en not_active Ceased
- 1998-08-11 CN CNB988084899A patent/CN1197578C/zh not_active Expired - Fee Related
- 1998-08-11 NZ NZ503414A patent/NZ503414A/xx not_active IP Right Cessation
- 1998-08-11 UA UA2000031668A patent/UA44370C2/uk unknown
- 1998-08-11 DK DK98939312T patent/DK1019058T3/da active
- 1998-08-11 AT AT98939312T patent/ATE326971T1/de active
- 1998-08-11 US US09/131,829 patent/US6172059B1/en not_active Expired - Lifetime
- 1998-08-11 BR BRPI9811994-0B1A patent/BR9811994B1/pt not_active IP Right Cessation
- 1998-08-11 HU HU0003093A patent/HU226063B1/hu not_active IP Right Cessation
- 1998-08-11 CZ CZ2000694A patent/CZ290667B6/cs not_active IP Right Cessation
- 1998-08-11 PL PL338828A patent/PL192361B1/pl unknown
- 1998-08-11 JP JP2000507380A patent/JP3472261B2/ja not_active Expired - Fee Related
- 1998-08-11 EP EP98939312A patent/EP1019058B1/en not_active Expired - Lifetime
- 1998-08-11 PE PE1998000718A patent/PE105799A1/es not_active Application Discontinuation
- 1998-08-11 IL IL13418598A patent/IL134185A/xx not_active IP Right Cessation
- 1998-08-11 KR KR10-2000-7001889A patent/KR100426516B1/ko not_active IP Right Cessation
- 1998-08-11 WO PCT/US1998/016581 patent/WO1999009990A1/en active IP Right Grant
- 1998-08-11 DE DE69834655T patent/DE69834655T2/de not_active Expired - Lifetime
- 1998-08-11 RU RU2000107825/14A patent/RU2196584C2/ru not_active IP Right Cessation
- 1998-08-11 TR TR2000/00490T patent/TR200000490T2/xx unknown
- 1998-08-11 ES ES98939312T patent/ES2265666T3/es not_active Expired - Lifetime
- 1998-08-21 MY MYPI98003819A patent/MY122272A/en unknown
- 1998-08-23 EG EG98398A patent/EG24075A/xx active
- 1998-08-24 HR HR980461A patent/HRP980461B1/xx not_active IP Right Cessation
- 1998-08-24 ID IDP981156A patent/ID21650A/id unknown
- 1998-08-24 TW TW087113878A patent/TW450812B/zh not_active IP Right Cessation
- 1998-08-24 CO CO98048247A patent/CO4970742A1/es unknown
- 1998-08-24 ZA ZA9807623A patent/ZA987623B/xx unknown
- 1998-08-25 AR ARP980104200A patent/AR016869A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 1998-11-01 SA SA98190680A patent/SA98190680B1/ar unknown
-
2000
- 2000-02-07 BG BG104133A patent/BG64337B1/bg active Active
- 2000-02-24 NO NO20000906A patent/NO326226B1/no not_active IP Right Cessation
- 2000-03-02 US US09/517,564 patent/US6255481B1/en not_active Expired - Lifetime
- 2000-11-20 HK HK00107393A patent/HK1027975A1/xx not_active IP Right Cessation
-
2006
- 2006-08-11 CY CY20061101147T patent/CY1105228T1/el unknown
-
2008
- 2008-10-21 CL CL2008003111A patent/CL2008003111A1/es unknown
-
2011
- 2011-10-14 AR ARP110103815A patent/AR083451A2/es active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108117T1 (el) | Φαρμακολογικως δραστικες ενωσεις με δυο ομοιοπολικως συνδεδεμενα δραστικα στοιχεια (αναστολεας διαυλων νατριου/αγωνιστης υποδοχεα ρ2υ2)για την αγωγη των βλεννογονιων επιφανειων | |
| IE831611L (en) | Topical anti-inflammatory compositions | |
| MY132705A (en) | Novel compounds with analgesic effect | |
| CA2478621A1 (en) | Botulinum toxin pharmaceutical compositions | |
| ME00520B (me) | Levodop/karbidop/entakapon farmaceutski preparat | |
| CA2274074A1 (en) | Novel compounds with analgesic effect | |
| BG102857A (en) | Antimycotic substance-containing and acetate buffer-containing compositions | |
| ATE225649T1 (de) | Arzneizubereitung bestehend aus rhein oder diacerhein mit verbesserter bioverfügbarkeit | |
| CA2157323A1 (en) | Gepirone dosage form | |
| SE9802206D0 (sv) | Novel compounds | |
| FR2712807B1 (fr) | Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale . | |
| ID21773A (id) | Anestetik lokal untuk penggunaan luar | |
| ES2108129T3 (es) | Nuevos derivados de pirazina, su preparacion y empleo. | |
| RS49808B (sr) | Farmaceutska suspenzija koja sadrži nevirapin hemihidrat | |
| CA2231176A1 (en) | Long active composition for rectal administration | |
| MY129946A (en) | Compound with gastric acid inhibitory effect and process for its preparation. | |
| GEP19991869B (en) | Amino Acid Derivatives of Substituted Quinoxaline 2,3-Dione Derivatives as Glutamate Receptor Antagonists | |
| DK320485D0 (da) | Ether-oxid-derivater af cyclopropylphenoler, deres fremstilling oganvendelse | |
| HUP9901659A2 (hu) | Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására | |
| ES2162678T3 (es) | Nuevos derivados diarilmetilideno furanicos, sus procedimientos de preparacion y sus utilizaciones en terapeutica. | |
| CO4910113A1 (es) | Composiciones farmaceuticas estabilizadas, a base de quinu- pristina y de dalfopristina y su preparacion | |
| EP0813866A3 (en) | Therapeutic agent for joint diseases | |
| RU2000107825A (ru) | Фармацевтическая суспензия, содержащая невирапин-полугидрат | |
| AP9801235A0 (en) | Erythromycin derivatives. | |
| ES2156763A1 (es) | Formulacion estables de solucion de apomorfina. |